TY - JOUR
T1 - Melatonin, refractory hypertension, myocardial ischemia and other challenges in nightly blood pressure lowering
AU - Zaslavskaya, Rina Mikhailovna
AU - Lilitsa, Galina Victorovna
AU - Dilmagambetova, G. S.
AU - Halberg, Franz
AU - Cornelissen-Guillaume, Germaine G
AU - Otsuka, Kuniaki
AU - Singh, Ram B.
AU - Stoynev, Alexander
AU - Ikonomov, Ognian
AU - Tarquini, Roberto
AU - Perfetto, Federico
AU - Schwartzkopff, Othild
AU - Bakken, Earl E.
N1 - Funding Information:
This study was supported by the US National Institutes of Health (GM-13981), and the University of Minnesota Supercomputing Institute.
PY - 2004/10
Y1 - 2004/10
N2 - A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.
AB - A test of the relative merits of timed melatonin for the treatment of cardiac ischemia as well as hypertension refractory to other drugs is documented against the background of earlier chronobiological studies on blood pressure (BP), disease risks, circadian hyper-amplitude-tension and melatonin effects broadly.
KW - Conventional treatment
KW - Drug-refractory hypertension
KW - MESOR-hypertension
KW - Melatonin
UR - http://www.scopus.com/inward/record.url?scp=22144479742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=22144479742&partnerID=8YFLogxK
U2 - 10.1016/S0753-3322(04)80021-0
DO - 10.1016/S0753-3322(04)80021-0
M3 - Article
C2 - 15754851
AN - SCOPUS:22144479742
SN - 0753-3322
VL - 58
SP - S129-S134
JO - Biomedicine and Pharmacotherapy
JF - Biomedicine and Pharmacotherapy
IS - SUPPL. 1
ER -